Lind Kevin Robert
Insider CIK 1677036 · ARNA Executive VP and CFO · AVTX Director · APMD Chief Executive Officer, Director · LBPH President and CEO, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| AVTX Avalo Therapeutics, Inc. | A Award deriv | 2026-09-30 | 2026-10-02 | 1,352 | $12.29 | $16.6K | 1,352 | SEC↗ |
| APMD Apnimed, Inc. | A Award deriv | 2026-08-03 | 2026-08-03 | 108,916 | — | $0 | 108,916 | SEC↗ |
| APMD Apnimed, Inc. | D To issuer deriv | 2026-08-03 | 2026-08-03 | 108,916 | — | $0 | 0 | SEC↗ |
| APMD Apnimed, Inc. | A Award deriv | 2026-08-03 | 2026-08-03 | 1,186,278 | — | $0 | 1,186,278 | SEC↗ |
| APMD Apnimed, Inc. | D To issuer deriv | 2026-08-03 | 2026-08-03 | 1,186,278 | — | $0 | 0 | SEC↗ |
| APMD Apnimed, Inc. | A Award deriv | 2026-08-03 | 2026-08-03 | 74,128 | — | $0 | 74,128 | SEC↗ |
| APMD Apnimed, Inc. | D To issuer deriv | 2026-08-03 | 2026-08-03 | 74,128 | — | $0 | 0 | SEC↗ |
| APMD Apnimed, Inc. | A Award deriv | 2026-08-03 | 2026-08-03 | 108,916 | — | $0 | 108,916 | SEC↗ |
| APMD Apnimed, Inc. | D To issuer deriv | 2026-08-03 | 2026-08-03 | 108,916 | — | $0 | 0 | SEC↗ |
| APMD Apnimed, Inc. | A Award deriv | 2026-08-03 | 2026-08-03 | 1,186,278 | — | $0 | 1,186,278 | SEC↗ |
| APMD Apnimed, Inc. | D To issuer deriv | 2026-08-03 | 2026-08-03 | 1,186,278 | — | $0 | 0 | SEC↗ |
| APMD Apnimed, Inc. | A Award deriv | 2026-08-03 | 2026-08-03 | 74,128 | — | $0 | 74,128 | SEC↗ |
| APMD Apnimed, Inc. | D To issuer deriv | 2026-08-03 | 2026-08-03 | 74,128 | — | $0 | 0 | SEC↗ |
| APMD Apnimed, Inc. | A Award deriv | 2026-07-30 | 2026-08-03 | 108,916 | — | $0 | 108,916 | SEC↗ |
| APMD Apnimed, Inc. | A Award deriv | 2026-07-30 | 2026-08-03 | 108,916 | — | $0 | 108,916 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | A Award deriv | 2026-06-30 | 2026-07-02 | 1,105 | $15.04 | $16.6K | 1,105 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | A Award deriv | 2026-06-02 | 2026-06-04 | 20,100 | — | $0 | 20,100 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | A Award deriv | 2026-03-31 | 2026-04-01 | 1,370 | $12.13 | $16.6K | 1,370 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | A Award deriv | 2025-12-31 | 2026-01-05 | 848 | $14.74 | $12.5K | 848 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | A Award deriv | 2025-10-01 | 2025-10-02 | 40,200 | — | $0 | 40,200 | SEC↗ |
| LBPH Longboard Pharmaceuticals, | D To issuer deriv | 2024-12-02 | 2024-12-02 | 332,134 | — | $0 | 0 | SEC↗ |
| LBPH Longboard Pharmaceuticals, | D To issuer deriv | 2024-12-02 | 2024-12-02 | 22,000 | — | $0 | 0 | SEC↗ |
| LBPH Longboard Pharmaceuticals, | D To issuer deriv | 2024-12-02 | 2024-12-02 | 255,377 | — | $0 | 0 | SEC↗ |
| LBPH Longboard Pharmaceuticals, | D To issuer deriv | 2024-12-02 | 2024-12-02 | 325,850 | — | $0 | 0 | SEC↗ |
| LBPH Longboard Pharmaceuticals, | D To issuer deriv | 2024-12-02 | 2024-12-02 | 192,783 | — | $0 | 0 | SEC↗ |
| LBPH Longboard Pharmaceuticals, | U Tender | 2024-12-02 | 2024-12-02 | 363,740 | $60.00 | $21.82M | 0 | SEC↗ |
| LBPH Longboard Pharmaceuticals, | M Exercise deriv | 2024-11-13 | 2024-11-13 | 12,808 | — | $0 | 255,377 | SEC↗ |
| LBPH Longboard Pharmaceuticals, | M Exercise | 2024-11-13 | 2024-11-13 | 12,808 | $3.12 | $40.0K | 443,740 | SEC↗ |
| LBPH Longboard Pharmaceuticals, | G Gift | 2024-11-13 | 2024-11-13 | 80,000 | — | $0 | 363,740 | SEC↗ |
| LBPH Longboard Pharmaceuticals, | A Award deriv | 2024-10-25 | 2024-10-29 | 22,000 | — | $0 | 22,000 | SEC↗ |
| LBPH Longboard Pharmaceuticals, | M Exercise deriv | 2024-08-12 | 2024-08-13 | 2,217 | — | $0 | 192,783 | SEC↗ |
| LBPH Longboard Pharmaceuticals, | M Exercise deriv | 2024-08-12 | 2024-08-13 | 80,265 | — | $0 | 268,185 | SEC↗ |
| LBPH Longboard Pharmaceuticals, | M Exercise | 2024-08-12 | 2024-08-13 | 2,217 | $4.20 | $9.3K | 430,932 | SEC↗ |
| LBPH Longboard Pharmaceuticals, | M Exercise | 2024-08-12 | 2024-08-13 | 80,265 | $3.12 | $250.4K | 428,715 | SEC↗ |
| LBPH Longboard Pharmaceuticals, | A Award deriv | 2024-02-08 | 2024-02-09 | 332,134 | — | $0 | 332,134 | SEC↗ |
| LBPH Longboard Pharmaceuticals, | A Award deriv | 2023-02-09 | 2023-02-10 | 325,850 | — | $0 | 325,850 | SEC↗ |
| LBPH Longboard Pharmaceuticals, | A Award deriv | 2022-02-09 | 2022-02-11 | 195,000 | — | $0 | 195,000 | SEC↗ |
| ARNA ARENA PHARMACEUTICALS INC | A Award deriv | 2020-03-01 | 2020-03-03 | 70,000 | — | $0 | 70,000 | SEC↗ |
| ARNA ARENA PHARMACEUTICALS INC | M Exercise deriv | 2020-02-13 | 2020-02-14 | 2,000 | — | $0 | 128,000 | SEC↗ |
| ARNA ARENA PHARMACEUTICALS INC | M Exercise deriv | 2020-02-13 | 2020-02-14 | 2,500 | — | $0 | 77,500 | SEC↗ |
| ARNA ARENA PHARMACEUTICALS INC | M Exercise | 2020-02-13 | 2020-02-14 | 2,500 | $19.40 | $48.5K | 5,957 | SEC↗ |
| ARNA ARENA PHARMACEUTICALS INC | M Exercise | 2020-02-13 | 2020-02-14 | 2,000 | $35.60 | $71.2K | 7,957 | SEC↗ |
| ARNA ARENA PHARMACEUTICALS INC | S Sale | 2020-02-13 | 2020-02-14 | 4,500 | $55.00 | $247.5K | 3,457 | SEC↗ |
| ARNA ARENA PHARMACEUTICALS INC | M Exercise deriv | 2019-10-14 | 2019-10-16 | 6,300 | — | $0 | 18,900 | SEC↗ |
| ARNA ARENA PHARMACEUTICALS INC | F Tax w/h | 2019-10-14 | 2019-10-16 | 3,091 | $47.32 | $146.3K | 3,457 | SEC↗ |
| ARNA ARENA PHARMACEUTICALS INC | M Exercise | 2019-10-14 | 2019-10-16 | 6,300 | — | $0 | 6,548 | SEC↗ |
| ARNA ARENA PHARMACEUTICALS INC | A Award deriv | 2019-01-04 | 2019-01-08 | 12,600 | — | $0 | 12,600 | SEC↗ |
| ARNA ARENA PHARMACEUTICALS INC | A Award deriv | 2019-01-04 | 2019-01-08 | 75,000 | — | $0 | 75,000 | SEC↗ |
| ARNA ARENA PHARMACEUTICALS INC | A Award deriv | 2018-01-19 | 2018-01-22 | 130,000 | — | $0 | 130,000 | SEC↗ |
| ARNA ARENA PHARMACEUTICALS INC | A Award deriv | 2017-02-13 | 2017-02-14 | 1,044,750 | — | $0 | 1,044,750 | SEC↗ |
| ARNA ARENA PHARMACEUTICALS INC | J Other | 2016-12-30 | 2017-02-14 | 625 | $1.21 | $756 | 1,250 | SEC↗ |
| ARNA ARENA PHARMACEUTICALS INC | J Other | 2016-09-30 | 2017-02-14 | 625 | $1.41 | $881 | 625 | SEC↗ |
| ARNA ARENA PHARMACEUTICALS INC | A Award deriv | 2016-06-15 | 2016-06-15 | 800,000 | — | $0 | 800,000 | SEC↗ |